• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/42

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

42 Cards in this Set

  • Front
  • Back
In cardiogenic shock preload would?
increase due to vasoconstriction shifting blood to the heart from the vessels and icnreased water retention
In cardiogenic shock venous hydrostatic pressure would?
Increase causing edema
In cardiogenic shock heart rate would?
increase to try and increase cardiac output
In cardiogenic shock afterload and resistance would?
Increased due to vasoconstriction making it harder for the heart to pump out blood. In some types of heart disease afterload may also be increased due to a strictured valve (pressure overload)
In cardiogenic shock contractility would>
decrease due to toxins, drugs, and some acquried types of disease like DCM, contractility may be OK in other types of heart diease but due to increased resistance such as in pressures overload or poor diastolic function such as in hypertorphic cardiomyopathy cardiac output will be poor.
In addition to the hemodynamic consequences of sympathetic stimulation, RAAS and vasopressin activation. What are other consequences?
-Sympathetic system and RAAS release may be directly toxic to the heart

-They may contribute to cardiac muscle necrosis, fibrosis, and excessive hypertrohy in addition to other abnormalities such release of inflammatory mediators and ractive oxygen species formation all of which can also be toxic to the heart.
What is the main goal in the treatment of most cases of cardiogenic shock and congestive heart failure and what type of drugs are used to accomplish this goal.
Decrease preload with diuretics
Decrease afterload with vasodilators
Increase constractility with positive inotropes in appropriate types of heart disease
Block sympathetic and renin angiotensin aldosterone system to prevent direct toxic effects to the heart.
How does treatment in emergency heart failure differ from stable heart failure
Emergency Tx:
- fast acting, stronger drugs
- concerned about hemodynamic consequences of the sympathetic and RAAS and not the direct toxic effects
-Tx that decrease direct toxic effects may actually be harmful in the short term (for examples beta blockers are used in stable heart failure but not unstable because in emergency situations the decreased heart rate and contractility may decrease cardiac output even further thereby worsening blood pressure and blood flow
- vasodilators may also be used in emergency to decrease resistance thereby improving blood flow. However often it is difficult to determine if vasoconstriction is helpful or harmful so these drugs are not always used immediately. In particular very strong vasodilators like nitroprusside which can easily cause overdilation resulting in vasodilatory shock.
- in emergency positive inotropes are god in appropriate cases. Also because the patient is stable these drugs are less likely to decompensate the patient and they do not need to be as strong
- also many of these drugs also block excessive sympathetic, and RAAS pathways (eg. ACE inhibitors, beta blockers) leading to a improvemet in heart function over the long term, despite the possibility of decompensating the patient via vasodilation, decreased contractility and decreased heart rate
what are some appropriate heart failure cases for positive inotropes?
cases that cause a decrease in contractility in particular if cause is reversible. used in cases where decreased contractility due to heart disease.
In what case might fluids or vasopressors be given to a patient in cardiogenic shock?
in cases of systolic failure and concurrent vasodilatory shock or hypovolemia in which preload is low due to these concurrent processes (vasodilatory shock or hypovolemic shock).
-drugs such as anesthetic drugs or sepsis could create this situation
-vasoconstrictors and positive inotropes may be helpful in cases of vsodilatory and cardiogenic shock because in these patients resistance would be low.
What drugs are used in emergency management of heart failure?
Loop Diuretics: furosemide
Some Vasodilators: nitroglycerine, nitroprusside, hydralazine, isosorbide dinitrate
Some Positive Inotropes: dobutamine, dopamine, bipyridine, amrinone, miklrinone
why are these drugs used in emergency management of heart failure and which are most commonly used>
- They are quick and strong acting drugs with high activity in diruretic, vasodilatory, or inotropic effect
- Remember these patients need quick acting drugs with a strong effect to control their abnormalities
- Diuretics are often a first emerency heart failure drug used because the pulmonary edema is what is generally causing the most problems and they are least likely to destabilize the patient
- Nitroglycerine is mainly a venous dilator that is commonly used to help relieve edema formation. Sometimes it is difficult to tell if arterial vasodilation will be a good or bad thing. In addition some of the vasodilators like nitroprusside or so strong they may cause excessive vasodiation
-positive inotropes can overwork the heart and are harmful in some for heart disease such as HCM
What is the goal of loop diuretics in emergency management of heart failure (ie. what is its cardiovascular pharmacological effect)?
diuresis will reduce blood volume and therefore decrease preload/volume overload thereby improving heart function in an overloaded heart. They can also decrease vascular hydrostatic pressure thereby decreasing edema formation
how do loop diuretics cause a diuretic effect?
due to inhibition of Na-K-2Cl symporter (cotransporter) at the luminal membrane of the thick ascending loop of henle. This inhibition results in decreased sodium reabsorption thereby causing diuresis
what effect do loop diuretic have on prostaglandins?
they may increase prostaglandins causing increases in renal blood flow an increase in venous capitance (prostaglandins cause vasodilation
What effect do loop diuretics have on prostaglandins?
they may increase prostaglandins causing increases in renal blood flow an increase in venous capitance (prostaglandins cause vasodilation)
How are loo diuretics given?
Orally and parenterally (IV is best in emergency and it is one of the only fast acting diuretic that is injectible)
What are the adverse effects of loop diuretics?
-Excessive administration can cause excessive volume depletion. This may worsen blood flow due to excessive decreases in preload resulting in decreased cardiac output and blood pressure (in other words this can cause hypovolemia

-electrolyte imbalances such as hyonatremia, hypkalemia, hypomagnesema

-systemic alkalosis

- other minor effects include hyperglycemia, cardiac arrythmias, hyperurecemia, ototoxicity, gastrointestinal disturbance, and hemotologic abnormalities (anemia, leukopenia)
-most likely of diuretics to cause dehydration and electrolyte abnormalities
What benefit do vasodilators have in emergency management of heart failure (what is the pharmacological effect on hemodrynamics)?
-arterial dilators reduce afterload allowing the heart to more effectively pump blood
- venous dilators reduce preload (may improve cardiac output in volume overloaded heart) and venous hydrastitics pressure (will reduce edema formation)
Does nitroglycerine mainly dilate veins or arteries?
veins
What is the mechanism of action of nitroglycerine?
causes the formation of nitric oxide (nitric oxide is a natural endogenous vasodilator)
How is nitroglycerine given?
topically
What are the main adverse effects of nitroglycerine?
Excessive vasodilation can decrease blood pressure/blood flow due to excessive decrease in preload and therefore decreased cardiac output and decreased resistance

Sometimes it is difficult to tell if vasoconstriction in heart failure is a good or bad thing (you may not want to block the vasodilation). Nitroglycerine is relatively safe however compared to balance strong vasodilators like nitroprusside
Does nitroprusside mainly dilate the veins or arteries?
both it is a balanced vasodilator
How does nitroprusside cause vasodilation?
increased formation of nitric oxide
How is nitroprusside given?
IV
what is an important metabolite of nitroprusside?
metabolized to cyanogen (cyanide radical) which is converted to thiocyanate which can than eliminated in urine feces and exhaled
what are adverse effect of nitroprusside?
excessive vasodilation can decrease arterial blood pressure and blood flow due to excessive decreases in resistance and pooling of blood in capillaries will decrease preload causing a decrease in cardiac output and therefore decreased blood pressure and blood flow.
-Prolonged use can cause cyanide toxicity and tolerance to vasodilatory effect
What drug is more likely to cause excessive vasodilation nitroprusside or nitroglycerine?
Nitroprusside is more likely because it is a much better vasodilatory in cases of severe heart failure but when giving you need continuous monitoring to avoid hypotension
Hydralazine is mainly an arterial or venous dilator?
arterial
less often used likely b/c it give no venodilation and is given orally which may be difficult to give and adjust when given to heart failure patients.
What is isosorbide dinatrate?
vasodilator like nitroprusside. it is mainly a venodilator
On what adrenergic receptors does dobutamine act on and which receptor causeas the positive inotrope effect?
It is a beta 1 agonist resulting in increased ionotrophy and chronotropy. It has very little to no beta 2 and alpha activity
Why does dobutamine have minimal effect on blood vessels and is this good in heart failure treatment?
It has no beta 2 and alpha activity so it has very little effect on blood vessels. This may be good in heart disease if you want to avoid vasodilation and vasoconstriction
How is dobutamine given?
IV can't be given orally degraded in GIT
in what type of heart disease is it best to use dobutamine?
heart disease associated with systolic heart failure like dilated cardiomyopathy
In what type of heart disease it is best not to use dobutamine (or any postive ionotrope)
heart disease assoicated with decreased contractility. it is not good in heart failure where systolic failure is normal such as hypertrophic cardiomyoptathy or stenosis
it may also wrosen heart failure i ncases of valvulr regurgitation
What are the adverse effects of dobutamine?
Tachyarrhythmia
may be helpful in short term but in long term increased oxygen consumption due to positive ionotropic and chronotropic effects may worsen heart disease
Why is dobutamine a first line agent as an inotrope in heart failure and what limits its use?
because it has mainly BETA1 activity with little effect on blood vessels and is least likely of the catecholamines to cause arrhythmias. The adverse effects mentioned above and need for continuous monitoring due to potential arrhythmias limit the use of dobutamine in general practice
what is another catecholamine that can be used as a positive ionotrope?
dopamine
is dopamine used at its low, mid, or high dose in heart disease?
mid dose is dose with beta activity thereby increasing cardiac contractility and rate
Adverse effects and uses of doapmine are similar to what other catecholamine and what is the main difference in receptor activity?
dobutamine. The difference is that dopamine has BETA 2 effect at mid dose along with BETA 1 effects and has ALPHA activity at higher doses. It also causes vasodilation due to dopamine receptor activiation. Vasodilation could potentially be a good thing in heart failure but it is sometimes hard to tell.
What other drugs can be used as positive ionotropes in emergency heart failure. Also what is the mechanism of action, pharmacological effect and adverse effects of these drugs?
Bipyridines (amrinone and milrinone)
They are phosphodiasterase inhibitors an can increase contractility and cause vessels dilations. Best in heart failure associated with poor contractility and should not be used if systolic function is not the problem.
Adverse effects are similar to catecholmines- arrhytmias